Focus, Scope and Objectives

Infectious Diseases and Herbal Medicine (IDHM) is an international, Open Access, peer-reviewed, authoritative journal providing basic and applied research. The Journal publishes original research reports, editorials, letters to the editor, rapid communications, case studies and reviews articles focusing on all aspects of infectious disease and herbal medicine including geographic, seasonal, and other risk factors that influence the transmission, diagnosis, pathogenesis, treatment, management, and prevention of infectious diseases caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi, and identifies global trends that have the potential to result in major epidemics. Infectious Diseases and Herbal Medicine coverage includes:

  • New knowledge on pathogens (viruses, bacteria, protozoa, helminths, fungi and prions) and on host-pathogen interactions.
  • Animal studies and in vitro experiments evaluating scientific efficacy of natural products used for the treatment of infectious diseases.
  • Immunity to pathogenic micro-organisms and systemic and mucosal immunology of infected organisms.
  • Investigation of pharmacological and molecular biological mechanisms of natural products for infectious diseases.
  • Epidemiological papers should provide new knowledge on pathogen-host interactions and/or host-population interactions related to infectious diseases.
  • The new technologies, such as nanotechnology, novel emulsification methods, and photodynamic therapy, in the formulation of natural products for infectious diseases.
  • Clinical trial of natural products for infectious diseases using scientific statistical analysis.

Articles that incorporate recent data into new methods, applications, or approaches (e.g., statistical modeling) that enhance infectious and herbal medicine are strongly encouraged.


Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. In recent times, natural products have been as widely used as chemical drugs against clinical diseases. Most chemical drugs that are widely used today were isolated from natural products, and thus natural products will continue to be important raw materials for the development of new drugs. However, since natural products are the byproducts of empirical medicine, they lack scientific validation. Currently, various scientific experiments are being conducted to fill this gap by evaluating the efficacy of natural product. These infectious diseases were conquered through the discovery of antibiotics and antiviral agents. However, emerging antibiotic-resistant strains and mutant microorganisms are more powerful than the existing antibiotic-resistant strains and mutant microorganisms. In particular, new emerging infectious diseases in the last 20 years have become global issues.

Infectious Diseases and Herbal Medicine brings together veterinary and human health researchers and policy-makers by providing a venue for publishing integrated and global approaches to infectious and herbal medicine. The Editors will consider papers that focus on timely collaborative and multi-disciplinary research in infectious and herbal medicine. This journal provides rapid publication of original papers, reviews, and potential discussion papers embracing this collaborative spirit. Papers should advance the scientific knowledge of the sources, transmission, prevention and control of infectious and be authored by scientists with expertise in areas such as natural products and epidemiology.

The audience of Infectious Diseases and Herbal Medicine might be veterinary and medical scientists, infectious disease specialists, virologists, public health researchers, pharmacy, agriculture, among others working in research institutes, universities, governmental organizations, private agencies, and pharmaceutical industry, among others.

Peer Review Process

Our journal follows the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA). The Editorial Board of IDHM will immediately screen all articles submitted for publication in that journal. The Editor-in-Chief assigns manuscripts to appropriate Associate Editors. Manuscripts may be rejected without external review if the Associate Editor, together with a Science Editor or the Editor-in-Chief, determines that the study does not significantly advance the field or the subject material is inappropriate for the IDHM readership. When papers are sent for external review, the choice of reviewers is made by the Editor-in-Chief or Associate Editor and may include reviewers suggested by the authors. Requests by authors to exclude a specific potential reviewer will be honored to the greatest extent possible if a compelling reason is provided. At least two, and generally three, expert referees are asked to review the manuscript in a timely manner and to assign a priority based on content, originality, quality, relevance, and interest. Those articles which fail to reach the scientific standards of the journal may be declined without further review. Every effort will be made to provide an editorial decision as to acceptance for publication within 4-6 weeks of submission. Review processing is performed by the editorial board members of IDHM or relevant experts from other universities or institutes. Minimum two independent reviewers’ approval followed by editor approval is required for the acceptance of any citable manuscript. The names of referees will not be made available to authors. However, referees will be informed as to the identity of the authors whose articles are subject to review. All members of the Editorial Board and referees are asked to declare any competing interests they may have in reviewing a manuscript.

Referees may request a revision of the article to be made. In this case, it is generally understood that only one revised version can be considered for a further appraisal under the peer-review system.

Authors are informed of the final decision, with applicable comments from reviewers and Editors included. Authors are expected to respond to reviewers’ comments and make appropriate revisions within 30 days. If on receiving the editorial decision concerning their manuscript authors are not satisfied they are invited to appeal to the Editorial Office. In cases in which this is considered appropriate, a second opinion on the manuscript will be requested.

Authors should note that a previously rejected manuscript by IDHM would not be re-evaluated.

Publication Frequency

All papers are published as soon as they have been accepted, by adding them to the "current" volume's Table of Contents.

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Pre- and post-prints

PAGEPress allows and encourages authors to deposit both their pre- and post-prints in Open-Access institutional archives or repositories. The primary benefit of pre- and post-print self-archiving is reaching a larger audience which enhances the visibility and impact of your research.


PAGEPress is currently working with the major databases and online resources, such as Scopus, Clarivate Web Of Science/InCites, Pubmed/Medline, PubMedCentral, Google Scholar, Directory of Open Access Journals (DOAJ), IndexCopernicus, Chemical Abstracts Service, to track the Infectious Diseases and Herbal Medicine articles. PAGEPress is also working closely with Scopus and Clarivate products to ensure that citation analysis of articles published in this Journal will be available as soon as possible.

Publication Ethics

PAGEPress strongly supports the mission of the COPE Code of Conduct and Best Practice Guidelines for Journal Editors; all individuals collaborating with PAGEPress are strongly invited to comply with this mission.

All animal studies must have been approved by the appropriate institutional review board(s), and a specific declaration of such approval must be made in a stand-alone paragraph at the end of the Methods section. All research studies involving animals must have been performed with great respect for animal welfare. The precise genotype, strain, source, number of backcrosses, sex, and age of animals studied must be provided in the manuscript. Any unnecessary manipulation or stress should be strictly avoided. If animals were euthanized, the method of euthanasia must be indicated.

The Editorial Board of our journals will immediately screen all articles submitted for publication in that journal. All submissions we receive are checked for plagiarism by using online available tools as iThenticate®. Any suspected misconduct ends up with a quick rejection and is then reported to the European Science Foundation and to the US Office of Research Integrity. The European Science Foundation released a Code of Conduct on Research Integrity, which is fully supported by our journals. All authors submitting papers to our journals are required to adopt these policies.

Below some online resource to help you in understanding plagiarism:

Conflict of Interests
Conflict of interest exists when an author (or the author's institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from negligible to great potential for influencing judgment. Not all relationships represent true conflict of interest. On the other hand, the potential for conflict of interest can exist regardless of whether an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, and paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.

All participants in the peer-review and publication process must disclose all relationships that could be viewed as potential conflicts of interest. Disclosure of such relationships is also important in connection with editorials and review articles, because it can be more difficult to detect bias in these types of publications than in reports of original research. Editors may use information disclosed in conflict-of-interest and financial interest statements as a basis for editorial decisions.

When authors submit a manuscript, whether an article or a letter, they are responsible for disclosing all financial and personal relationships that might bias their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. Authors should do so in the manuscript on a conflict-of-interest notification page, providing additional detail, if necessary, in a cover letter that accompanies the manuscript. Increasingly, individual studies receive funding from commercial firms, private foundations, and government. The conditions of this funding have the potential to bias and otherwise discredit the research.

Scientists have an ethical obligation to submit creditable research results for publication. Moreover, as the persons directly responsible for their work, researchers should not enter into agreements that interfere with their access to the data and their ability to analyze them independently, and to prepare and publish manuscripts. Authors should describe the role of the study sponsor, if any, in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. If the supporting source had no such involvement, the authors should so state. Biases potentially introduced when sponsors are directly involved in research are analogous to methodological biases.

Editors may request that authors of a study funded by an agency with a proprietary or financial interest in the outcome sign a statement, such as "I had full access to all of the data in this study and I take complete responsibility for the integrity of the data and the accuracy of the data analysis." Editors should be encouraged to review copies of the protocol and/or contracts associated with project-specific studies before accepting such studies for publication. Editors may choose not to consider an article if a sponsor has asserted control over the authors' right to publish.

Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and they should recuse themselves from reviewing specific manuscripts if the potential for bias exists. As in the case of authors, silence on the part of reviewers concerning potential conflicts may mean either that conflicts exist and the reviewer has failed to disclose them or conflicts do not exist. Reviewers must therefore also be asked to state explicitly whether conflicts do or do not exist. Reviewers must not use knowledge of the work, before its publication, to further their own interests.

Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement in any of the issues they might judge. Other members of the editorial staff, if they participate in editorial decisions, must provide editors with a current description of their financial interests (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists.

Informed Consent
PAGEPress journals strictly follow the ICMJE Protection of Research Participants policy detailed at Patients have a right to privacy that should not be violated without informed consent. When informed consent has been obtained, editors may request authors to provide a copy before making the editorial decision. Manuscripts must be reviewed with due respect for authors' confidentiality. In submitting their manuscripts for review, authors entrust editors with the results of their scientific work and creative effort, on which their reputation and career may depend. Authors' rights may be violated by disclosure of the confidential details during review of their manuscript. Reviewers also have rights to confidentiality, which must be respected by the editor. Confidentiality may have to be breached if dishonesty or fraud is alleged but otherwise must be honored. Editors must not disclose information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or ultimate fate) to anyone other than the authors and reviewers. This includes requests to use the materials for legal proceedings.

Protection of Human Subjects and Animals in Research
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the World Medical Association (2016 revision,) and from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare. When reporting experiments on ecosystems involving non-native species, Authors are bound to ensure compliance with the institutional and national guide for the preservation of native biodiversity.